CASE REPORT
|
doi:10.20944/preprints202304.0705.v1
Subject:
Medicine And Pharmacology,
Gastroenterology And Hepatology
Keywords:
Drug-induced liver injury; ocrelizumab; hepatotoxicity
Online: 21 April 2023 (09:41:29 CEST)
ARTICLE
|
doi:10.20944/preprints202405.2030.v1
Subject:
Neuroscience And Neurology,
Medicine And Pharmacology
Keywords:
disease modified treatment; multiple sclerosis; neurofilament; no evidence of disease activity; ocrelizumab; real world
Online: 30 May 2024 (13:32:26 CEST)
REVIEW
|
doi:10.20944/preprints202402.0963.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
POMS; Pediatric Onset Multiple Sclerosis; Disease-modifying therapies; DMT; Pediatric MS; Interferons; Finglolimod; Teriflunomide; Cyclophosphamide; Rituximab; Ocrelizumab; Daclizumab; Alemtuzumab; Natalizumab; Ofatumumab; Siponimod; Vitamin D; TCR vaccine; Stem cell therapy; Glatiramer acetate; Azathioprine; Dimethyl fumarate; Mitoxantrone
Online: 19 February 2024 (14:52:05 CET)